Burkina Faso cuts medicine prices by up to 72% to boost healthcare access
The Government of Burkina Faso has announced a historic reduction in the prices of essential generic medicines and medical consumables, with cuts reaching as much as 72%. This bold initiative, supported by a 3 billion FCFA financial commitment, is set to take effect on March 1, 2026, aiming to enhance equitable access to healthcare across the nation.
Key details of the price reduction initiative
The decision follows a Council of Ministers meeting held on February 12, 2026, where authorities approved significant price adjustments for essential generic medicines, specific health products, and medical consumables distributed by the Central Purchasing Agency of Essential Generic Medicines (CAMEG). This move is part of a broader strategy to make healthcare more affordable and accessible to all citizens.
Breakdown of price reductions by category
- Tablets and capsules: Up to 67.27% reduction in prices.
- Injectable medications: Price cuts of up to 53.47%.
- Syrups and suspensions: A 20% decrease in costs.
- Medical consumables: Price reductions of up to 72.73%.
Financial backing and long-term goals
To ensure the success of this reform, the Burkinabè government is allocating 3 billion FCFA in financial support. This funding aims to alleviate the financial burden on households, improve access to treatments, and promote fairness in healthcare delivery. The initiative builds on a previous price reduction implemented in May 2025, which had an estimated budgetary impact of nearly 5 billion FCFA, further demonstrating the government’s commitment to affordable healthcare.
Dr. Robert Lucien Jean-Claude Kargougou, Minister of Health, emphasized that these measures are designed to guarantee high-quality healthcare services for every citizen, regardless of their economic background. By making medicines more affordable, the government seeks to reduce out-of-pocket expenses and enhance overall public health outcomes.
Impact on healthcare equity and affordability
This landmark decision reflects Burkina Faso’s ongoing efforts to strengthen its healthcare system and ensure that essential medicines are within reach for all residents. The price reductions are expected to have a significant positive impact on both urban and rural communities, fostering greater healthcare equity and improving the quality of life for millions of people.
The initiative also underscores the government’s dedication to transparency and accountability in healthcare spending, as it continues to prioritize the well-being of its population through cost-effective and sustainable policies.
